AFC Agro Biotech Limited (DSE:AFCAGRO)

Market Cap	794.99M -22.5%
Revenue (ttm)	434.50M -41.2%
Net Income	799.87K -98.3%
EPS	0.01 -98.4%
Shares Out	115.22M
PE Ratio	993.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101,055
Average Volume	163,508
Open	7.30
Previous Close	7.30
Day's Range	6.80 - 7.30
52-Week Range	4.00 - 11.70
Beta	-0.36
RSI	62.79
Earnings Date	Dec 24, 2025

About AFC Agro Biotech

AFC Agro Biotech Limited engages in the manufacture and sale of bio-pharmaceuticals and bio-chemical products in Bangladesh. The company produces various products for the pharma, food, and textile sectors from agricultural raw materials, such as corn starch, potato starch, molasses, AFCABL, and other nutrients. It also offers Erythromycin, a macrolide antibiotic that is used for people who have an allergy to penicillin, and for respiratory tract infections; L-Lysine, an amino acid for building block protein in the body; and acetic acid, a chemi...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2010
• Employees: 181
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AFCAGRO

Financial Performance

In fiscal year 2022, AFC Agro Biotech's revenue was 701.88 million, an increase of 55.07% compared to the previous year's 452.64 million. Earnings were 25.63 million, an increase of 45.27%.